Jung Jee-Hee, Yun Jeong-Ho, Um Yoo-Jung, Jung Ui-Won, Kim Chang-Sung, Choi Seong-Ho, Cho Kyoo-Sung
Department of Periodontology, College of Dentistry, Yonsei University, Seoul, Korea.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Mar;111(3):298-305. doi: 10.1016/j.tripleo.2010.05.011. Epub 2010 Sep 26.
The aim of this study was to evaluate the osteogenic and space-providing effect of rhBMP-2 produced in an Escherichia coli expression system (ErhBMP-2) with absorbable collagen block (ACB) as the carrier system in the rat calvarial defect model.
Eight-millimeter diameter calvarial defects were created in 60 male Sprague-Dawley rats. The animals were divided into 6 groups containing 10 animals each that received sham-surgery control (no material applied), ACB control (ACB alone), or ErhBMP-2/ACB (ACB loaded with 0.025 mg/mL ErhBMP-2). Histological and histometric analysis was performed after 2- and 8-week healing intervals.
On histological observation, the level of bone formation in the defects was generally higher at 8 weeks than at 2 weeks. Surgical implantation of ErhBMP-2/ACB resulted in the enhanced bone regeneration compared with controls. Moreover, the collagen remnants of ACB appeared to be completely resorbed in ACB control and ErhBMP-2/ACB group after 8 weeks. Histometic analysis revealed that the ErhBMP-2/ACB group had a significantly greater augmented area, new bone area, and new bone ratio after 2 and 8 weeks than both control groups. However, there was no difference between 2 and 8 weeks in the ErhBMP-2/ACB group in all aspects of the augmented area, new bone area, and new bone ratio (P < .05).
ErhBMP-2 loaded on ACB can induce favorable bone formation in the rat calvarial defect model, but this collagen carrier in block type did not fulfill the space-maintaining expectations for bone formation by ErhBMP-2.
本研究旨在评估以可吸收胶原块(ACB)为载体系统,在大肠杆菌表达系统中产生的重组人骨形态发生蛋白-2(ErhBMP-2)在大鼠颅骨缺损模型中的成骨和提供空间的效果。
在60只雄性Sprague-Dawley大鼠中制造直径8毫米的颅骨缺损。将动物分为6组,每组10只,分别接受假手术对照(未应用材料)、ACB对照(仅ACB)或ErhBMP-2/ACB(负载0.025 mg/mL ErhBMP-2的ACB)。在愈合2周和8周后进行组织学和组织计量学分析。
组织学观察显示,缺损处的骨形成水平在8周时总体上高于2周。与对照组相比,手术植入ErhBMP-2/ACB可促进骨再生。此外,8周后,ACB对照和ErhBMP-2/ACB组中ACB的胶原残余物似乎完全被吸收。组织计量学分析显示,ErhBMP-2/ACB组在2周和8周后的增大面积、新骨面积和新骨比例均显著大于两个对照组。然而,ErhBMP-2/ACB组在增大面积、新骨面积和新骨比例的所有方面,2周和8周之间均无差异(P < 0.05)。
负载于ACB的ErhBMP-2可在大鼠颅骨缺损模型中诱导良好的骨形成,但这种块状胶原载体未达到ErhBMP-2对骨形成的空间维持预期。